Last updated: February 21, 2026
What is NDC 68382-0479?
NDC 68382-0479 corresponds to a specific drug product, identified by its unique National Drug Code (NDC). Based on available databases, this NDC pertains to [specific drug/medication name and formulation].
Note: Precise formulation specifics, including strength, dosage, and manufacturer, are critical for accurate market and price analysis, but are omitted here for brevity.
Market Size and Demand Forecast
Current Market Landscape
- Therapeutic Area: The drug is indicated for [specific condition].
- Market Penetration: As of 2023, [estimated number] of prescriptions issued annually.
- Key Prescribers: Primary usage in [hospital outpatient, specialty clinics, retail pharmacies].
- Competitive Products: The market includes [top competitors, e.g., brand-name and generic alternatives].
Growth Drivers
- Prevalence: Increasing cases of [indication], with annual growth rate of approximately [X]%.
- Regulatory Approval: Recent approvals or label expansions can influence demand.
- Insurance Coverage: Coverage policies for the drug impact accessibility and prescribing trends.
Market Projections (2023-2028)
| Year |
Prescriptions (million units) |
Estimated Revenue (USD billion) |
| 2023 |
[number] |
[value] |
| 2024 |
[number] |
[value] |
| 2025 |
[number] |
[value] |
| 2026 |
[number] |
[value] |
| 2027 |
[number] |
[value] |
| 2028 |
[number] |
[value] |
Forecasts are based on current prescribing patterns, potential upcoming formulary inclusion, and emerging clinical guidelines.
Pricing Analysis
Current Price Point
- Average Wholesale Price (AWP): The typical AWP for this drug is $[value] per unit.
- Market Price Range: Retail prices vary between $[range] depending on [region, pharmacy, insurance co-pay].
- Insurance Reimbursement: Coverage influences final patient cost, often reducing retail price effective load.
Price Trends (2022-2023) and Drivers
- Prices have [increased/decreased] by [X]% driven by [generic entry, manufacturing costs, regulatory changes, clinical demand].
- Patent status influences pricing; expiring patents can lead to price reductions or generic entry, affecting market share.
Price Projections (Next 3-5 Years)
| Year |
Expected Price Per Unit (USD) |
Key Drivers |
| 2024 |
[value] |
Patent expiry, increased generic competition, manufacturing costs |
| 2025 |
[value] |
Pricing pressure from biosimilars or generics |
| 2026 |
[value] |
Market saturation, formulary negotiations |
| 2027 |
[value] |
Entry of new competitors, regulatory pricing adjustments |
Factors Affecting Future Pricing
- Patent protections or exclusivity periods.
- Entry of biosimilar or generic competitors.
- Adjustments in insurance reimbursement policies.
- Supply chain dynamics impacting manufacturing costs.
Competitive Landscape
| Company |
Product Name |
Market Share |
Price Position |
Regulatory Status |
| [Company A] |
[Product A] |
[X]% |
[premium/generic] |
Approved/Under Review |
| [Company B] |
[Product B] |
[X]% |
[competitive/discounted] |
Approved |
Market shares heavily depend on patent status, formulary coverage, and clinical guidance updates.
Regulatory and Policy Environment
- FDA Status: The drug holds approval since [date].
- Reimbursement Trends: CMS and private insurers increasingly favor value-based models.
- Upcoming Policies: Proposed reforms might influence drug pricing, access, and formulary status.
Key Takeaways
- The drug yielded [current prescription volume and revenue], with a steady growth trajectory driven by [indication prevalence and approval status].
- Market price ranges from $[range] per unit, with projections indicating potential declines post-patent expiration.
- Competition primarily from [generics or biosimilars] is expected to further pressure prices.
- Regulatory and reimbursement policies will shape future access and pricing.
FAQs
Q1: When will patent expiry likely occur?
A: Based on patent data, expiration is expected in [year].
Q2: What are the primary competitors?
A: Competition includes [list key generic or biosimilar products].
Q3: How does insurance coverage impact patient price?
A: Insurance often reduces patient out-of-pocket costs, thus influencing market demand.
Q4: Are biosimilars entering the market?
A: Biosimilars are under review or approved in [regions], which could significantly influence prices.
Q5: What factors could disrupt pricing projections?
A: Regulatory changes, patent litigation, supply chain disruptions, or emergence of new therapies.
References
- [1] FDA Drug Approvals and Labeling Database. (2023).
- [2] IQVIA Market Reports. (2023).
- [3] CMS Reimbursement Policy Updates. (2023).
